336 related articles for article (PubMed ID: 10588453)
1. Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection.
Thomas HI; Barrett E; Hesketh LM; Wynne A; Morgan-Capner P
J Clin Virol; 1999 Oct; 14(2):107-18. PubMed ID: 10588453
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the specificity of a commercial human parvovirus B19 IgM assay.
Jensen IP; Vestergaard BF
Clin Diagn Virol; 1997 Feb; 7(3):133-7. PubMed ID: 9126681
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of tests for detection of parvovirus B19 IgG and IgM.
de Ory F; Minguito T; Echevarría JE; Del Mar Mosquera M; Fuertes A
APMIS; 2014 Mar; 122(3):223-9. PubMed ID: 23763266
[TBL] [Abstract][Full Text] [Related]
4. [Monitoring of implementation of international programs of poliomyelitis eradication and measles and rubella elimination in the Republic of Belarus].
Zh Mikrobiol Epidemiol Immunobiol; 2012; (1):21-30. PubMed ID: 22442967
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.
Rezaei F; Sarshari B; Ghavami N; Meysami P; Shadab A; Salimi H; Mokhtari-Azad T
J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067
[TBL] [Abstract][Full Text] [Related]
6. Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil.
Oliveira MI; Curti SP; Figueiredo CA; Afonso AM; Theobaldo M; Azevedo RS; Durigon EL
Rev Saude Publica; 2002 Apr; 36(2):155-9. PubMed ID: 12045795
[TBL] [Abstract][Full Text] [Related]
7. Human parvovirus B19 infections among exanthematic diseases notified as measles.
Cubel RC; Siqueira MM; Santos EO; Pires MF; Cruz CM; Nascimento JP
Rev Soc Bras Med Trop; 1997; 30(1):15-20. PubMed ID: 8993105
[TBL] [Abstract][Full Text] [Related]
8. Microsphere-Based IgM and IgG Avidity Assays for Human Parvovirus B19, Human Cytomegalovirus, and Toxoplasma gondii.
Wang Y; Hedman L; Nurmi V; Ziemele I; Perdomo MF; Söderlund-Venermo M; Hedman K
mSphere; 2020 Mar; 5(2):. PubMed ID: 32188754
[TBL] [Abstract][Full Text] [Related]
9. Investigation of measles IgM-seropositive cases of febrile rash illnesses in the absence of documented measles virus transmission, State of São Paulo, Brazil, 2000-2004.
Ciccone FH; Carvalhanas TR; Afonso AM; Flannery B; Waldman EA
Rev Soc Bras Med Trop; 2010; 43(3):234-9. PubMed ID: 20563487
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of serological procedures used for the diagnosis of viral exanthema in laboratories participating in the measles elimination plan].
de Ory F; Sanz JC; Echevarría JE; Mosquera Mdel M; Guisasola ME;
Enferm Infecc Microbiol Clin; 2004; 22(6):319-22. PubMed ID: 15228897
[TBL] [Abstract][Full Text] [Related]
11. Detection of measles, mumps, and rubella antibodies in saliva using antibody capture radioimmunoassay.
Perry KR; Brown DW; Parry JV; Panday S; Pipkin C; Richards A
J Med Virol; 1993 Jul; 40(3):235-40. PubMed ID: 8355022
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis of parvovirus B19 infection in hematological patients with partial red cell aplasia of the bone marrow].
Iaguzhinskaia OE; Pivnik AV; Fevraleva IS; Sudarikov AB; Lisovina IuS; Loginova IV; Shitareva IV
Ter Arkh; 2001; 73(8):50-6. PubMed ID: 11599268
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of determining low-avidity IgG antibodies in the diagnosis of primary rubella infection in pregnant women].
Lafarga B; Noguera FJ; Pérez MC; Copado R; García A; Soria E
Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):413-8. PubMed ID: 9887628
[TBL] [Abstract][Full Text] [Related]
14. Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops.
Enders M; Weidner A; Rosenthal T; Baisch C; Hedman L; Söderlund-Venermo M; Hedman K
J Infect Dis; 2008 Jan; 197(1):58-62. PubMed ID: 18171285
[TBL] [Abstract][Full Text] [Related]
15. Etiology of measles suspect cases reported in 2006-2007 in Poland.
Siennicka J; Stefanoff P; Rogalska J; Trzcińska A
Przegl Epidemiol; 2011; 65(1):39-44. PubMed ID: 21735834
[TBL] [Abstract][Full Text] [Related]
16. Validation of monoplex assays detecting antibodies against Corynebacterium diphtheriae and Clostridium tetani toxins, rubella virus and parvovirus B19 for incorporation into Multiplex Serology.
Brenner N; Butt J; Bomfim IL; Tabatabai J; Pawlita M; Schnitzler P; Waterboer T
Methods; 2019 Apr; 158():44-53. PubMed ID: 30703462
[TBL] [Abstract][Full Text] [Related]
17. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
[TBL] [Abstract][Full Text] [Related]
18. Assessment of IgM enzyme immunoassay and IgG avidity assay for distinguishing between primary and secondary immune response to rubella vaccine.
Hamkar R; Jalilvand S; Mokhtari-Azad T; Nouri Jelyani K; Dahi-Far H; Soleimanjahi H; Nategh R
J Virol Methods; 2005 Dec; 130(1-2):59-65. PubMed ID: 16026863
[TBL] [Abstract][Full Text] [Related]
19. Identification of human parvovirus B19 among measles and rubella suspected patients from Cuba.
de Los Ángeles Ribas M; Tejero Y; Cordero Y; Pérez D; Sausy A; Muller CP; Hübschen JM
J Med Virol; 2019 Jul; 91(7):1351-1354. PubMed ID: 30817853
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of human parvovirus (B19) and rubella virus infections in urban and remote rural areas in northern Brazil.
de Freitas RB; Wong D; Boswell F; de Miranda MF; Linhares AC; Shirley J; Desselberger U
J Med Virol; 1990 Dec; 32(4):203-8. PubMed ID: 1964474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
